Bank Of America Corp Recursion Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,165,425 shares of RXRX stock, worth $6.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,165,425

Previous 1,841,465 36.71%

Holding current value

$6.99 Million

Previous $13.8 Million 44.39%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.92 - $8.6 $4 Million - $5.81 Million	-676,040 Reduced 36.71%	1,165,425 $7.68 Million
Q2 2024 Aug 14, 2024	BUY	$7.35 - $10.05 $1.02 Million - $1.39 Million	138,551 Added 8.14%	1,841,465 $13.8 Million
Q1 2024 May 15, 2024	BUY	$9.13 - $15.52 $8.38 Million - $14.2 Million	917,637 Added 116.86%	1,702,914 $17 Million
Q4 2023 Feb 14, 2024	BUY	$5.09 - $10.79 $2.82 Million - $5.98 Million	554,559 Added 240.36%	785,277 $7.74 Million
Q2 2023 Aug 14, 2023	SELL	$4.56 - $9.94 $1.49 Million - $3.24 Million	-326,292 Reduced 58.58%	230,718 $1.72 Million
Q1 2023 May 12, 2023	BUY	$6.42 - $9.64 $867,637 - $1.3 Million	135,146 Added 32.04%	557,010 $3.72 Million
Q4 2022 Feb 10, 2023	BUY	$7.16 - $12.7 $1.6 Million - $2.83 Million	222,998 Added 112.13%	421,864 $3.25 Million
Q3 2022 Nov 14, 2022	BUY	$7.83 - $13.6 $725,441 - $1.26 Million	92,649 Added 87.23%	198,866 $2.12 Million
Q2 2022 Aug 12, 2022	BUY	$5.04 - $9.26 $113,586 - $208,692	22,537 Added 26.93%	106,217 $864,000
Q1 2022 May 16, 2022	SELL	$6.16 - $18.03 $538,969 - $1.58 Million	-87,495 Reduced 51.11%	83,680 $599,000
Q4 2021 Feb 08, 2022	BUY	$16.14 - $21.86 $2.33 Million - $3.16 Million	144,668 Added 545.77%	171,175 $2.93 Million
Q3 2021 Nov 15, 2021	BUY	$19.03 - $41.33 $354,528 - $769,977	18,630 Added 236.51%	26,507 $610,000
Q2 2021 Sep 13, 2021	BUY	$18.0 - $37.42 $141,786 - $294,757	7,877 New	7,877 $288,000

Others Institutions Holding RXRX

# of Institutions

287

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.08B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Recursion Pharmaceuticals, Inc. Transaction History